CCJ Cameco

Research status: Primary-source verified through Q2 2026. Valuation basis: US$97.74 closing price on 14 August 2026; operating figures are in Canadian dollars unless stated otherwise.

Cameco provides the most direct new factor exposure in the group: uranium contracting, fuel services and a 49% interest in Westinghouse. First-half uranium adjusted EBITDA rose 5% to C$676M, 2026 consolidated revenue guidance increased to C$3.32–3.57B, and the uranium realized-price outlook increased to C$91–96/lb. However, Q2 showed the volatility behind the theme: uranium sales volume fell 18%, gross profit fell 27%, purchased pounds were materially more expensive than produced pounds, and Cameco's share of Westinghouse adjusted EBITDA fell 54% year over year. The long-term nuclear thesis is credible, but the current US$42.5B market value prices substantial success. Keep CCJ to a small discovery position and require either a better entry or stronger contract/production evidence before scaling.

Investment case

Cameco combines tier-one uranium production in stable jurisdictions, conversion and fuel services, long-term utility contracts, and a 49% interest in Westinghouse. This creates exposure across the nuclear fuel cycle rather than to spot uranium alone. Contract discipline can preserve uncommitted resources for better pricing, while Westinghouse adds a large installed reactor service and fuel base plus new-build optionality.

The variant perception is that security-of-supply concerns, utility contracting and new reactor demand will sustain stronger uranium and fuel-cycle economics for longer than prior cycles. The counterpoint is that the stock already reflects a powerful nuclear renaissance, while realized prices can lag spot markets, production is operationally concentrated, and Westinghouse new-build work is capital- and execution-intensive.

Verified operating baseline

• First-half 2026 uranium adjusted EBITDA: C$676M, up 5%; Q2 uranium adjusted EBITDA was C$252M, down 28% because of delivery timing and lower planned volumes.
• Q2 uranium sales volume: 7.1M lb, down 18%; average realized price: C$93.13/lb, up 15%.
• Q2 uranium gross profit: C$158M, down 27%; unit cost of sales rose 26% to C$70.81/lb.
• 2026 outlook: 19.5–21.5M lb owned uranium production, 29–32M lb sales, and consolidated revenue of C$3.32–3.57B.
• 2026 uranium realized-price outlook: C$91–96/lb; uranium revenue outlook: C$2.70–2.91B.
• Cameco's share of Westinghouse Q2 adjusted EBITDA: C$163M, down 54%; 2026 company outlook for its share remains US$370–430M.
• At Q2, cash and short-term investments were approximately C$1.11B, debt C$1.00B, and net cash approximately C$116M.
• At year-end 2025, uranium long-term commitments totaled about 230M lb, averaging approximately 28M lb annually over the following five years; fuel-services contracted volume was about 83M kgU of UF6.

Valuation scenarios

PowerFund share-price scenarios based on US$97.74 on 14 August 2026. Direct share values are used because CCJ combines Canadian-dollar mining/fuel economics and equity-accounted Westinghouse earnings; dividends are excluded.

24 months

Probability-weighted working value: approximately $114, or 7.9% annualised.

60 months

Probability-weighted working value: approximately $145, or 8.2% annualised. At today's price, CCJ is more useful as a small factor diversifier and asymmetric nuclear option than as a large base-case return engine.

• New long-term uranium and conversion contracts at prices and terms that improve portfolio realized-price sensitivity.
• Owned production meeting the 19.5–21.5M lb outlook with lower reliance on high-cost market purchases.
• Cigar Lake and McArthur River/Key Lake operating reliably after maintenance or third-party processing disruptions.
• Uranium realized prices moving toward or above the C$91–96/lb outlook while unit costs normalize.
• Westinghouse delivering the US$370–430M 2026 adjusted-EBITDA range for Cameco's share.
• Definitive U.S. AP1000 agreements, additional international new-build awards, or higher-margin fuel/service contracts.
• Distributions from Westinghouse and JV Inkai converting equity earnings into parent cash.

• Valuation: the current market value embeds a strong uranium price, successful contracting and meaningful Westinghouse growth.
• Commodity cycle: uranium prices and contracting can reverse as supply, inventories, enrichment or policy conditions change.
• Operational concentration: Cigar Lake, McArthur River/Key Lake and third-party mills create outage and logistics risk.
• Cost mismatch: market purchases and product loans can cost substantially more than internally produced pounds.
• Contract structure: ceilings and delivery timing can cause realized prices and cash flow to lag spot-market enthusiasm.
• Kazakhstan exposure: JV Inkai production, transport, dividends and regulation add geopolitical and timing risk.
• Westinghouse execution: new-build projects require financing, partners, permits and disciplined project delivery; equity earnings do not equal parent cash.
• Currency and regulation: U.S.-dollar sales, Canadian-dollar costs, environmental obligations, tax disputes and nuclear policy affect results.

Warning — investigate and freeze additions

• Owned production tracks below the 19.5M lb low end or unit cost of sales remains above C$70/lb without a temporary maintenance explanation.
• Contracting slows, realized-price sensitivity deteriorates, or market purchases exceed plan without offsetting economics.
• Westinghouse's expected 2026 contribution moves below US$370M adjusted EBITDA for Cameco's share.
• The share price rises faster than uranium contract prices and cash-flow revisions, expanding the valuation disconnect.

Reduce — normally trim 25–50%

• Uranium production, sales-volume or realized-price guidance is reduced by more than 10%.
• A core operation suffers an outage that materially impairs twelve-month delivery coverage or forces uneconomic replacement purchases.
• Uranium gross margin remains below 20% for two quarters despite supportive market prices.
• Westinghouse misses its annual adjusted-EBITDA range by more than 15% or consumes material incremental owner capital.
• Net debt rises materially to fund operating shortfalls, acquisitions or new-build exposure rather than value-accretive capacity.

Invalidate — exit unless a documented exception is approved

• A multi-year impairment or loss of a tier-one uranium asset prevents Cameco from meeting contract commitments economically.
• Contract discipline breaks: long-duration volumes are committed at terms that destroy upside or require structurally loss-making purchases.
• Westinghouse experiences a major project loss, regulatory failure or capital requirement that materially impairs Cameco's investment.
• Nuclear policy, reactor closures and utility contracting enter a structural multi-year reversal rather than a cyclical pause.
• Accounting, reserve, environmental, tax or joint-venture evidence makes reported asset value or cash conversion unreliable.

Cameco's advantage is the combination of large, high-grade Canadian resources, licensed conversion/fuel capability, a long utility contracting history, and Westinghouse's reactor-service and fuel footprint. Few public companies provide comparable exposure across uranium, conversion, fabrication, services and reactor technology.

Competition and customer alternatives still matter. Kazatomprom is the largest low-cost uranium producer, Orano spans mining and fuel-cycle services, and utilities can use inventories, secondary supplies and alternative contract structures. Cameco's scarcity value is real, but commodity economics and customer bargaining power remain; the company should not be valued as a monopoly or as a simple proxy for spot uranium.

1. Build a five-year contract-delivery model showing base-escalated versus market-related pricing, ceilings/floors and annual volume ranges.
2. Reconcile owned production, Inkai purchases, market purchases, product loans, inventory and deliveries by quarter.
3. Track Cigar Lake and McArthur River/Key Lake production, unit costs, maintenance and third-party processing constraints.
4. Separate Westinghouse core services/fuel EBITDA from new-build milestones; track distributions, capex and owner funding.
5. Stress-test CCJ at uranium prices of US$60, $80, $100 and $130/lb with Canadian-dollar and purchase-cost sensitivities.
6. Refresh scenarios after Q3 2026 and every material contracting, production or AP1000 update; keep discovery sizing until the base-case return clears PowerFund's hurdle.

Next scheduled review: Q3 2026 results; earlier following a production outage, major contract, Westinghouse funding request or uranium-price dislocation.